Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8076 - 8100 of 10589 in total

Arimoclomol

Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.
Investigational

5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine

Experimental

PAT-SM6

Investigational

Paclitaxel docosahexaenoic acid

A combination of docosahexaenoic Acid (a natural fatty acid) and paclitaxel (an anticancer drug) being studied in the treatment of cancer. It is a type of mitotic inhibitor.
Investigational

5-monophosphate-9-beta-D-ribofuranosyl xanthine

Experimental

(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid

Experimental

Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate

Experimental

1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate

Experimental

N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE

Experimental

N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide

Experimental

3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL

Experimental

Astragalus mongholicus root polysaccharides

Investigational

2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one

Experimental

TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL

Experimental

Furaprofen

Investigational

Oleandomycin

Oleandomycin is a macrolide antibiotic, though it is less effective than erythromycin. It is synthesized from strains of Streptomyces antibioticus.
Vet approved
Matched Iupac: … (3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl ... ]oxy}-6-hydroxy-12-{[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,7,8,11,13,15-hexamethyl …
Matched Salts cas: … 7060-74-4 …

Aloxistatin

Investigational

ALLO-715

ALLO-715 is an allogeneic chimeric antigen receptor T Cell therapy targeting B cell maturation antigen (BCMA).
Investigational

Lenvervimab

Investigational

Timolumab

Timolumab is a recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1).
Investigational

Bisantrene

Investigational
Matched Salts cas: … 71439-68-4 …

AVR-RD-05

AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced ex vivo with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme. It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).
Investigational

Ziltivekimab

Ziltivekimab is under investigation in clinical trial NCT06200207 (A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation).
Investigational

1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide

Experimental

(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE

Experimental
Displaying drugs 8076 - 8100 of 10589 in total